N/A
N=23
Middle School Parent Module for a Brief Bullying Intervention Program
Bullying
Bottom Line
View on ClinicalTrials.gov: NCT06002347 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Knowledge and Confidence to Support Defenders — 33.52; 38.90 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- STAC Parent Module for Middle School (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Boise State University
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge and Confidence to Support Defenders |
33.52; 38.90 | — |
| PRIMARY Confidence Managing Bullying |
12.00; 13.75 | — |
| PRIMARY Comfort Managing Bullying |
11.04; 13.70 | — |
| PRIMARY Parental Role |
12.17; 13.95 | — |
| PRIMARY Bullying Self-Efficacy |
20.44; 22.50 | — |
| PRIMARY Communication Self-Efficacy |
25.39; 27.75 | — |
| PRIMARY Attitudes About Bullying |
24.22; 25.65 | — |
| PRIMARY Intention to Use Parent STAC Strategies |
14; 19; 19; 19 | — |
| SECONDARY Acceptability of the Parent STAC Training |
20; 18; 18; 19; 20; 18 | — |
| SECONDARY Interest in Receiving Bullying Prevention |
20 | — |
| SECONDARY Features of a Technology-Based Program |
14; 18; 20; 18; 15; 10 | — |
Summary
This study evaluates the feasibility and short-term outcomes of a parent training designed as a companion module to a bullying bystander intervention (STAC) for middle school students in rural communities. The aim of this project is to provide a brief, low-cost intervention that can be easily disseminated as part of a school-based bullying prevention program to address this important public health problem.
Eligibility Criteria
Inclusion Criteria
- Being a parent of an adolescent enrolled in grades 6, 7, or 8 in a participating middle school in Idaho.
- Speaks and reads English.
- Consents to participate.
Exclusion Criteria
- Speaks and reads only a language other than English.
- Does not consent for participation.
Data sourced from ClinicalTrials.gov (NCT06002347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.